Takamol Ventures

Takamol Ventures is a Riyadh-based VC writing seed and Series A checks in the $1M to $5M range, focused on enterprise technology and AI applications that drive operational efficiencies. Within healthcare, the firm engages with health IT software where there is a credible enterprise GTM and an applied AI angle that materially improves operational performance for Saudi providers, payers, or government health programs. The fund’s positioning is enterprise-first rather than consumer-oriented, which fits a Saudi commercial environment where large institutional buyers in healthcare, insurance, and government drive the most consequential procurement decisions. The geographic focus is Saudi Arabia with selective expansion into the broader GCC. The right founder profile is a B2B enterprise technology founder with proven product-market fit elsewhere or strong early traction in MENA, who is making a serious commitment to Saudi market entry and has the operating maturity to navigate Saudi enterprise sales cycles. The wrong fit is a B2C wellness brand, a research-stage biotech, or a tourist startup that wants Saudi capital without a real local commercial strategy. The right entry path is through Riyadh enterprise technology networks, through Saudi-connected investors at Sanabil, STV, Raed, and Derayah, through Vision 2030-aligned ecosystem programs, and through warm introductions from regional co-investors and from Saudi government-affiliated advisors. When pitching, lead with the enterprise GTM, the AI capability that materially changes the cost or outcome curve, the Saudi-specific commercial strategy including which institutional buyers you intend to land, and the operating discipline of the team. Avoid generic regional decks that treat Saudi Arabia as one of many MENA markets. Caveats: Takamol’s healthcare-specific operating expertise is generalist rather than deep, so founders should layer healthtech-specialist co-investors onto the cap table. The fund’s relatively recent vintage also means the track record is still being built, so external validation through follow-on rounds led by larger institutional investors will be the eventual proof point. Use Takamol as a credible Saudi enterprise technology partner for a B2B AI-for-healthcare business with serious local commercial ambition.